本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioCryst製藥

9.41
-0.1500-1.57%
盤後9.36-0.0499-0.53%19:58 EDT
成交量:319.49萬
成交額:3,006.60萬
市值:23.60億
市盈率:7.78
高:9.56
開:9.51
低:9.34
收:9.56
52周最高:11.31
52周最低:6.00
股本:2.51億
流通股本:2.18億
量比:0.66
換手率:1.47%
股息:- -
股息率:- -
每股收益(TTM):1.21
每股收益(LYR):1.21
淨資產收益率:587.33%
總資產收益率:43.21%
市淨率:-19.81
市盈率(LYR):7.78

資料載入中...

2020/03/13

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/10

重要事件披露

Current report, item 1.02
2020/03/05

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2020/03/05

重要事件披露

Current report, items 8.01 and 9.01
2020/02/25

重要事件披露

Current report, items 5.02 and 9.01
2020/02/18

重要事件披露

Current report, items 8.01 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

重要事件披露

Current report, items 8.01 and 9.01
2020/01/22

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/15

重要事件披露

Current report, items 8.01 and 9.01
2020/01/13

重要事件披露

Current report, items 5.02, 7.01, and 9.01
2019/12/11

重要事件披露

Current report, items 8.01 and 9.01
2019/11/21

重要事件披露

Current report, items 1.01 and 9.01